Internal Medicine, Endocrinology, Diabetes, & Metabolism · Trujillo Alto, PR
NPI
1023443983
Since 2013
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
Calle la Cruz, 305
Trujillo Alto, PR, 00976
Phone (787) 293-2700
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$2.8M
8,011 prescriptions
Company payments, 2025
$414
From 6 companies
Medicare prescription drug claims, 2024
In 2024, the drug Paula V Jeffs-Gonzalez prescribed most often to Medicare patients was Synthroid (Levothyroxine Sodium), with 833 prescriptions and refills. In total Paula V Jeffs-Gonzalez wrote 8,011 Medicare prescriptions that cost $2.8M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-10-08.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Synthroid Levothyroxine Sodium | 833 | 1,786 | 269 | $84K |
| Ozempic Semaglutide | 579 | 600 | 103 | $570K |
| Trulicity Dulaglutide | 516 | 518 | 85 | $512K |
| Trijardy Xr Empaglifloz/Linaglip/Metformin | 496 | 544 | 100 | $334K |
| Synjardy Empagliflozin/Metformin Hcl | 457 | 475 | 79 | $293K |
| Lantus Insulin Glargine,hum.Rec.Anlog | 311 | 433 | 85 | $36K |
| Glipizide Generic | 271 | 352 | 74 | $2,762 |
| Glipizide Er Glipizide | 270 | 347 | 66 | $3,629 |
| Metformin Hcl Generic | 241 | 377 | 71 | $1,594 |
| Jardiance Empagliflozin | 224 | 261 | 48 | $160K |
| Humulin 70-30 Insulin Nph Hum/Reg Insulin Hm | 220 | 299 | 50 | $23K |
| Xigduo Xr Dapaglifloz Propaned/Metformin | 211 | 217 | 36 | $137K |
| Metformin Hcl Er Metformin Hcl | 189 | 254 | 59 | $1,797 |
| Atorvastatin Calcium Generic | 184 | 286 | 69 | $1,598 |
| Jentadueto Linagliptin/Metformin Hcl | 180 | 194 | 38 | $103K |
Brand drugs: 5,259 claims; generic drugs: 2,165 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paula V Jeffs-Gonzalez $414 ($414 in general payments such as food, travel and fees) from 6 companies. The largest payer was Novo Nordisk Inc with $152.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.